PIMJS
EDIT icon

PKO Investment Management Joint-Stock’s Editas Medicine EDIT Stock Holding History

PKO Investment Management Joint-Stock’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-113,833
Closed -$4.08M – 93
2018
Q2 		$4.08M Sell
113,833
-78,559
-41% -$2.78M 0.85% 26
2018
Q1 		$6.38M Buy
192,392
+41,500
+28% +$1.48M 1.43% 20
2017
Q4 		$4.64M Buy
150,892
+52,590
+53% +$1.32M 1.15% 20
2017
Q3 		$2.36M Buy
98,302
+87,963
+851% +$1.67M 0.64% 31
2017
Q2 		$173K Buy
+10,339
New +$186K 0.06% 72

Other funds holding EDIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

PKO Investment Management Joint-Stock's EDIT Position: Q3 2018 in Review

PKO Investment Management Joint-Stock sold out of Editas Medicine (EDIT) in Q3 2018, closing a stake of 113,833 shares — an estimated $4.08M sold.

PKO Investment Management Joint-Stock first reported a position in EDIT in Q2 2017 and held it in 5 quarters. The position peaked at $6.38M in Q1 2018. 199 funds tracked by Wall St. Rank hold EDIT as of Q3 2018.

  • PKO Investment Management Joint-Stock reported no remaining Editas Medicine position as of Q3 2018 after selling out during the quarter.
  • PKO Investment Management Joint-Stock sold 113,833 Editas Medicine shares in Q3 2018, an estimated $4.08M.
  • PKO Investment Management Joint-Stock first reported a position in Editas Medicine in Q2 2017 and held it in 5 quarters.
  • PKO Investment Management Joint-Stock's Editas Medicine position peaked at $6.38M in Q1 2018.
  • 199 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2018.

Based on PKO Investment Management Joint-Stock's 13F filing for Q3 2018, filed 13 Mar 2025.